Status: retired, Primitive. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689526014 | Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3689527017 | Product containing precisely ceftazidime (as ceftazidime pentahydrate) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Is a | Ceftazidime only product in parenteral dose form | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Plays role | Antibacterial therapeutic role | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Is a | Ceftazidime-containing product | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has active ingredient | Ceftazidime | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Is a | Ceftazidime-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has presentation strength numerator value | 250 | false | Inferred relationship | Some | 1 | |
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has presentation strength denominator unit | Vial | false | Inferred relationship | Some | 1 | |
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has unit of presentation | Vial | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has precise active ingredient | Ceftazidime pentahydrate | false | Inferred relationship | Some | 1 | |
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Ceftazidime (as ceftazidime pentahydrate) 250 mg powder for solution for injection vial | Has BoSS | Ceftazidime | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR